Skip Nav Destination
Issues
The Wnt Pathway Inhibitor RXC004 Blocks Tumor Growth and Reverses Immune Evasion in Wnt Ligand–dependent Cancer Models
Caroline Phillips; Inder Bhamra; Catherine Eagle; Eimear Flanagan; Richard Armer; Clifford D. Jones; Matilda Bingham; Peter Calcraft; Alicia Edmenson Cook; Ben Thompson; Simon A. Woodcock
ZL-1211 Exhibits Robust Antitumor Activity by Enhancing ADCC and Activating NK Cell–mediated Inflammation in CLDN18.2-High and -Low Expressing Gastric Cancer Models
Hiroyasu Konno; Tracey Lin; Renyi Wu; Xinchuan Dai; Shou Li; Grace Wang; Min Chen; Wenying Li; Lina Wang; Bee-Chun Sun; Zhen Luo; Tom Huang; Yuping Chen; John Zhang; Qiuping Ye; David Bellovin; Bing Wan; Lishan Kang; Christopher Szeto; Karl Hsu; Omar Kabbarah
A Ketogenic Diet in Combination with Gemcitabine Increases Survival in Pancreatic Cancer KPC Mice
Natalia E. Cortez; Cecilia Rodriguez Lanzi; Brian V. Hong; Jihao Xu; Fangyi Wang; Shuai Chen; Jon J. Ramsey; Matthew G. Pontifex; Michael Müller; David Vauzour; Payam Vahmani; Chang-il Hwang; Karen Matsukuma; Gerardo G. Mackenzie
SLFN11 Negatively Regulates Noncanonical NFκB Signaling to Promote Glioblastoma Progression
Mariafausta Fischietti; Frank Eckerdt; Ricardo E. Perez; Jamie N. Guillen Magaña; Candice Mazewski; Sang Ho; Christopher Gonzalez; Lukas D. Streich; Elspeth M. Beauchamp; Amy B. Heimberger; Aneta H. Baran; Feng Yue; C. David James; Leonidas C. Platanias
Bintrafusp Alfa, an Anti-PD-L1:TGFβ Trap Fusion Protein, in Patients with ctDNA-positive, Liver-limited Metastatic Colorectal Cancer
Van K. Morris; Michael J. Overman; Michael Lam; Christine M. Parseghian; Benny Johnson; Arvind Dasari; Kanwal Raghav; Bryan K. Kee; Ryan Huey; Robert A. Wolff; John Paul Shen; June Li; Isabel Zorrilla; Ching-Wei D. Tzeng; Hop S. Tran Cao; Yun Shin Chun; Timothy E. Newhook; Nicolas Vauthey; Dzifa Duose; Raja Luthra; Cara Haymaker; Scott Kopetz
Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer
Ryan M. Murphy; Jason Tasoulas; Alessandro Porrello; Miranda B. Carper; Yi-Hsuan Tsai; Alisha R. Coffey; Sunil Kumar; Peter YF. Zeng; Travis P. Schrank; Bentley R. Midkiff; Stephanie Cohen; Ashley H. Salazar; Michele C. Hayward; D. Neil Hayes; Andrew Olshan; Gaorav P. Gupta; Anthony C. Nichols; Wendell G. Yarbrough; Chad V. Pecot; Antonio L. Amelio
Whole-exome Sequencing of Nigerian Prostate Tumors from the Prostate Cancer Transatlantic Consortium (CaPTC) Reveals DNA Repair Genes Associated with African Ancestry
Jason A. White; Ernest T. Kaninjing; Kayode A. Adeniji; Paul Jibrin; John O. Obafunwa; Chidiebere N. Ogo; Faruk Mohammed; Ademola Popoola; Omolara A. Fatiregun; Olabode P. Oluwole; Balasubramanyam Karanam; Isra Elhussin; Stefan Ambs; Wei Tang; Melissa Davis; Paz Polak; Moray J. Campbell; Kathryn R. Brignole; Solomon O. Rotimi; Windy Dean-Colomb; Folake T. Odedina; Damali N. Martin; Clayton Yates
NetrinG1+ Cancer-Associated Fibroblasts Generate Unique Extracellular Vesicles that Support the Survival of Pancreatic Cancer Cells Under Nutritional Stress
Kristopher S. Raghavan; Ralph Francescone; Janusz Franco-Barraza; Jaye C. Gardiner; Débora B. Vendramini-Costa; Tiffany Luong; Narges Pourmandi; Anthony Andren; Alison Kurimchak; Charline Ogier; Paul M. Campbell; James S. Duncan; Costas A. Lyssiotis; Lucia R. Languino; Edna Cukierman
Real-world Validation of TMB and Microsatellite Instability as Predictive Biomarkers of Immune Checkpoint Inhibitor Effectiveness in Advanced Gastroesophageal Cancer
Ryon P. Graf; Virginia Fisher; James Creeden; Alexa B. Schrock; Jeffrey S. Ross; Halla Nimeiri; Geoffrey R. Oxnard; Samuel J. Klempner
Pathway-based Approach Reveals Differential Sensitivity to E2F1 Inhibition in Glioblastoma
Alvaro G. Alvarado; Kaleab Tessema; Sree Deepthi Muthukrishnan; Mackenzie Sober; Riki Kawaguchi; Dan R. Laks; Aparna Bhaduri; Vivek Swarup; David A. Nathanson; Daniel H. Geschwind; Steven A. Goldman; Harley I. Kornblum
Pharmacologic Inhibition of SHP2 Blocks Both PI3K and MEK Signaling in Low-epiregulin HNSCC via GAB1
Richard Kurupi; Konstantinos V. Floros; Sheeba Jacob; Ayesha T. Chawla; Jinyang Cai; Bin Hu; Madhavi Puchalapalli; Colin M. Coon; Rishabh Khatri; Giovanna Stein Crowther; Regina K. Egan; Ellen Murchie; Patricia Greninger; Krista M. Dalton; Maninderjit S. Ghotra; Sosipatros A. Boikos; Jennifer E. Koblinski; Hisashi Harada; Yue Sun; Iain M. Morgan; Devraj Basu; Mikhail G. Dozmorov; Cyril H. Benes; Anthony C. Faber
The MDM2 Inhibitor Navtemadlin Arrests Mouse Melanoma Growth In Vivo and Potentiates Radiotherapy
Katrine Ingelshed; Diana Spiegelberg; Pavitra Kannan; Linnéa Påvénius; Jessica Hacheney; Long Jiang; Silke Eisinger; Danai Lianoudaki; Dilraj Lama; Francisca Castillo; Cecilia Bosdotter; Warren W. Kretzschmar; Omayma Al-Radi; Nicolas Fritz; Eduardo J. Villablanca; Mikael C. I. Karlsson; Fredrik Wermeling; Marika Nestor; David P. Lane; Saikiran K. Sedimbi
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.